The University of Western Australia

Professor Sean Hood

Professor
Queen Elizabeth II Medical Centre

Contact details

Address

Queen Elizabeth II Medical Centre
The University of Western Australia (M521)
35 Stirling Highway
CRAWLEY WA 6009
Australia

Phone

9346 2393

Fax

9346 3828

Email

Sean.Hood@uwa.edu.au

Qualifications

MB BS W.Aust., MSc Maastricht, FRANZCP

Biography

Teaching Philosophy

Objectives (to what end?)

The students that I teach in medicine come to the course with many advantages. They are selected from amongst the brightest and most driven university applicants, many have relatives who are medical professionals, and they have largely been successful in previous academic endeavours. Obsessional personality traits and the ability to memorise minutiae are rewarded in their training and are over represented in this group. By the time they reach clinical years medical students are usually strategic learners – they have learnt to rapidly deconstruct PBL and lecture structures to extract the core pieces of information that they believe they need, discarding the rest.

Yet good doctors are something greater than the sum of these parts, and much of their developmental process involves challenging these pre-existing modes of learning and perception. There is an abundance of content available to students these days, but the skills to process and integrate this are less prevalent. Flexibility and critical reasoning are vital in approaching clinical scenarios in which (relatively) diminishing healthcare resources, inequities and regional politics increasingly confound our practice. The ability to take a step back and grasp the meta-issues is a mark of clinical maturity that can be nurtured at a medical student level.

Evidence Based Medicine (EBM) has become both mantra and a misnomer – an axiom of current medical curricula with rare comments on its limitations, political context or consideration of alternatives. A holistic grasp of the medical research process is needed. Trainee doctors need to realise that medical information is a dynamic area with few absolutes, subject to both internal and external demands. Our students often fail to appreciate the extent to which these external forces dictate the content and delivery of lecturers’ material. We work within an imperfect framework with imprecise tools; this is a mirror to clinical realities also. The great risk of this model is to diminish the veracity, relevance and usefulness of our teaching.

Thus, the themes in my teaching philosophy are critical pedagogy, utility, and fidelity. In the first, I seek to challenge student’s habitual ways of perceiving the world and their hunger for content by offering perspectives informed by a grasp of process and the influence of context. In the second, I aim to use my clinical experience to help students assign appropriate weightings to the information available to them. In the third, I endeavour to preserve a high quality of teaching, research and scholarship in the context of external forces that at times work to diminish these.


Methods (by what means?)

Economic pressures are motivating students to demand higher quality teaching and learning, however this can lead to a drive to preferentially provide surface approaches to learning with manifest immediate goals. Deep approaches, encouraging integrated understanding and insight, can have less obvious but more profound impact in the longer term. Issues such as clinical ethics and the societal context of mental illness are examples of themes that benefit from a broad perspective.

This is a canon of modern tertiary education. We would do better to integrate the theory with traditional sources of wisdom such as clinical experience, astute observation, and mastery through repetition and refinement. Consideration of multiple or idiosyncratic methods is frequently indicated. Although the term “Adult Learner” is part of this tertiary educational canon, we are informed that in contrast to non-Adult Learners these students need to be especially motivated to listen to us, that information should be presented to them in easily digestible chunks, that the content needs to be overtly relevant and practical, that they need to be entertained by consideration of multiple modes of delivery, etc. Outside of the teaching context, these are all features of childhood not maturity! Surely we don’t have to infantilise our students in order to effectively engage with them – I endeavour to treat my students as adults with all of the obligations and privileges that come with adult relationships.

I work predominantly in a clinical teaching environment, which has introduced the additional elements of external clinical and service realities. Finding a way to balance such competing demands is an ongoing task of the academic clinician. Striving to maximise the potential of the Evidenced Based Medicine / Problem Based Learning approaches whilst minimising the hyperbole and distortions associated with their common implementations is a long-term teaching goal.

Experimentation, a willingness to consider alternative methods of delivery, and empathy for the student perspective informs my teaching methodology.


Evaluation (to what degree?)

Evaluation of the effectiveness of these occurs on multiple levels. Formal SPOT & SURF questionnaires have some utility. Peer observation of my teaching offers a much-needed alternative perspective, although its implementation needs to be carefully handled. Personal communication with my students & year representatives is a vital resource that continues to educate and at times surprise me. The most important outcomes remain difficult to quantify – including the facilitation of sound medical graduates and professional satisfaction.


Why?

I am not afraid to convey the enthusiasm that I have for my discipline to my students. In fact, I hope that it is infectious! We currently have a great need not only to recruit research academic staff into my field but more broadly to ensure that society’s push for more doctors does not lead to a decline of standards (see The Faculty Of Medicine and Dentistry Board Minutes 26/10/04). The recent doubling of local undergraduate medical student places, including graduate-entry options, presents us with new challenges and opportunities. I am passionate about nurturing the development of our medical students and junior doctors.

Students come to my Discipline of Psychiatry with media-fuelled misconceptions, variable interest, and often a little apprehension. A number will find it to be a very challenging on a clinical and personal level, some will struggle with this, and I have increasing sought involvement with such students in my academic and clinical work. My practice is to engage with my students as individuals and as future colleagues to help them with their clinical journeys, and to guide them if they lose their way. Whilst successes are rewarding and necessary it has been my experience that I have often learnt much more from my mistakes. Encouraging students to continue to progress even though they may at times stumble is a primary reason why I teach.

Key research

Psychopharmacology of Anxiety Disorders

Publications

Editorials

REF 1.Stampfer HG, Hood SD. Circadian rhythms: keeping pace with developments. Med.J.Aust. 2009;191(9):479-80. [33%]
REF 2.Robinson HM, Bell CJ, Hood SD, Nutt DJ, 2006, Dopamine and social anxiety disorder (Editorial), Revista Brasileira de Psiquiatria. 2006;28(4):263-4. [35%]
REF 3.Argyropoulos S, Hood SD, Nutt DJ. Social Phobia: illness or illusion? (Editorial). Acta Psychiatrica Scandinavica 2001;103(4):241-423. [40%]

Peer-Reviewed Journals

REF 4.Garcia de Miguel B, Nutt DJ, Hood SD, Davies SJC. Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements – a systematic review. (In press) J Psychopharmacol, 2010. [25%]
REF 5.Bell C., Hood SD, Potokar J, Nash J, Adrover M, Frampton C, Hince D, Rich A, Argyropoulos s, Nutt DJ. Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder. Psychopharmacology. 2011;213(2-3):593-602.[25%]
REF 6.Hood SD, Melichar JK, Taylor LG, Kalk N, Edwards TR, Hince DA, Lenox-Smith A, Lingford-Hughes AR, Nutt DJ. Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. J.Psychopharmacol. 2011;25(1):78-86. [50%]
REF 7.Hood SD, Orr KGD, Bennett L, Davies SJC. Severe laryngeal dystonia in a patient receiving zuclopenthixol "Acuphase" and fluoxetine. Australasian Psychiatry; 2010 18(2): 174-176. [75%]
REF 8.Hood SD, Hince DA, Davies SJC, Argyropoulos S, Robinson HM, Potokar J, Nutt DJ. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder. Psychopharmacology. 2010;208(2):223-32 [50%]
REF 9.Christmas DM, Menon G, Hood SD. Recent Developments in Anxiety Disorders. Frontiers in CNS Drug Discovery. 2010, 1, 184-205. [33%]
REF 10.Hood S, Potokar J, Davies S, Hince D, Morris K, Seddon K, Nutt D, Argyropoulos S. Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants. Journal of Psychopharmacology. 2010; 24(5): 709-716 [50%]
REF 11.Sinclair LI, Christmas DM, Hood SD, Potokar JP, Robertson A, Isaac A, Srivastava S, Nutt DJ, Davies SJ. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br.J.Psychiatry 2009;194(6):483-90.
REF 12.Hood SD. SSRIs as Antihypertensives in Patients with Autonomic Panic Disorder. Psychiatric Times. February 2009. 26(2):30-36. [100%]
REF 13.Corchs F, Nutt DJ, Hood S, Bernik M. 5HT provides resilience to trauma-related exposure in SSRIs-recovered PTSD. Biological Psychiatry 2009.66(1): 17-24 [25%]
REF 14.Shufflebotham, J., Wetherall, M. A., Hince, D. A., Hood, S. D., Lightman, S. L., Nutt, D. J., Probert, C., & Potokar, J., Women with diarrhoea predominant irritable bowel syndrome show an increased pressor response to 35% carbon dioxide stress challenge. Stress 2009;12(1):30-6 [20%]
REF 15.Hood S, Davies S. Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al. Psychopharmacology. 2009; 203(4): 831-833.[75%]
REF 16.Hood S, O’Neil G, Hulse G. The Role of Flumazenil in the Treatment of Benzodiazepine Dependence: Physiological & Psychological Profiles. Journal of Psychopharmacology. 2009;23(4):401-9 [75%]
REF 17.Christmas D, Hood S, Nutt D. Potential Novel Anxiolytic Drugs. Current Pharmaceutical Design. 2008;14(33):3534-46. [33%]
REF 18.Hood S, Shufflebotham J, Hendry J, Hince D, Rich A, Probert C, Potokar J. Irritable Bowel Syndrome (IBS) patients exhibit depressive and anxiety scores in the subsyndromal range. The Open Psychiatry Journal. 2008; 2: 12-22. [75%]
REF 19.Davies SJC, Jackson P, Lewis G, Hood SD, Nutt DJ, Potokar J. Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients? Journal of Affective Disorders 2008; 111(2-3): 344-350. [25%]
REF 20.Nash J, Sargent P, Rabiner E, Hood SD, Argyropoulos SV, Grasby P, Nutt DJ. A positron emission tomography study of serotonin 5-HT1A receptor availability in untreated and recovered patients with panic disorder. British Journal of Psychiatry 2008; 193(3): 229-234. [20%]
REF 21.Harvey R, Smith M, Abraham N, Hood S, Tannenbaum D. The Hurricane Choir: Remote mental health monitoring of participants in a community-based intervention in the post-Katrina period. Journal of Health Care for the Poor and Underserved 2007; 18(2):356-61. [33%]
REF 22.Robinson H, Hood S. Social Anxiety Disorder - A Review of Pharmacological Treatments. Current Psychiatry Reviews 2007; 3: 95-122 [65%]
REF 23.Argyropoulos SV, Ploubidis GB, Wright T, Palm M, Hood S, Nash J, Taylor AC, Forshall S, Anderson IM, Nutt DJ, Potokar J. Development and validation of the Generalized Anxiety Disorder Inventory (GADI). Journal of Psychopharmacology 2007; 21 (2): 145-152. [10%]
REF 24.Christmas D, Hood S. Recent Developments in Anxiety Disorders. Recent Patents on CNS Drug Discovery 2006;1:289-98. [60%]
REF 25.Shufflebotham J, Hood S, Hendry J, Hince DA, Morris K, Nutt D, Probert C, Potokar J. Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. American Journal of Gastroenterology 2006;101(11):2582-7. [10%]
REF 26.Nutt D, Argyropoulos S, Hood S, Potokar J. Generalized anxiety disorder: A comorbid disease. European Neuropsychopharmacology 2006;16 Suppl 2:S109-S118. [15%]
REF 27.Hood SD, Hince DA, Robinson H, Cirillo M, Christmas D, Kaye JM. Serotonin regulation of the human stress response. Psychoneuroendocrinology 2006;31(9):1087-97. [70%]
REF 28.Davies SJC, Hood SD, Argyropoulos SV, Morris KV, Bell C, Witchel HJ, Jackson PR, Nutt DJ, Potokar J. Depleting Serotonin enhances both cardiovascular and psychological stress reactivity in humans. Journal of Clinical Psychopharmacology. 2006;26(4):414-8. [33%]
REF 29.Hood SD, Bell C, Nutt DJ. Acute tryptophan depletion. Part I: Rationale and Methodology. Australian and New Zealand Journal of Psychiatry 2005;39:558-64. [65%]
REF 30.Bell C, Hood SD, Nutt DJ. Acute tryptophan depletion. Part II: Clinical Effects and Implications. Australian and New Zealand Journal of Psychiatry 2005;39:565-74. [45%]
REF 31.Argyropoulos SV, Hood SD, Adrover M, Bell C, Rich A, Nash J, Rich N, Witchel H, Nutt DJ. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biological Psychiatry 2004; 56(7): 503-9 [40%]
REF 32.McDonough S, Wynaden D, Finn M, McGowan S, Chapman R, Hood SD. Emergency Department Mental Health Triage Consultancy Service: An evaluation of the first year of the service. Accident and Emergency Nursing 2004; 12: 31-38 [33%]
REF 33.Hood SD, Argyropoulos SV, Nutt DJ. New directions in the treatment of anxiety disorders. Expert Opinion on Therapeutic Patents 2003;13(4):401-24. [85%]
REF 34.Wynaden D, Chapman R, McGowan S, McDonough S, Finn M, Hood SD. Emergency Department Mental Health Triage and Consultancy Service: A qualitative evaluation. Accident and Emergency Nursing 2003;11(3):158-65 [15%]
REF 35.Argyropoulos S, Bailey JE, Hood SD, Kendrick AH, Rich A, Laszlo G, Nash JR, Lightman SL and Nutt DJ. Inhalation of 35% CO2 results in activation of the HPA axis in healthy volunteers. Psychoneuroendocrinology. 2002; 27: 715-729 [30%]
REF 36.Bell C, Forshall S, Adrover M, Nash J, Hood SD, Argyropoulos S, Rich A, Nutt, DJ. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. Journal of Psychopharmacology 2002; 16 (1): 5-14 [20%]
REF 37.Hood SD, Alderton D, Castle DJ. OCD: Treatment and Treatment Resistance. Australasian Psychiatry 2001;19:118-27 [85%]
REF 38.Hood SD, Argyropoulos S, Nutt DJ. Arthritis and Serotonergic Antidepressants. Journal of Clinical Psychopharmacology 2000;21(4):458-61.[85%]
REF 39.Hood, S.D., Argyropoulos, S., Nutt DJ. Agents in Development for Anxiety Disorders: Current Status and Future Potential. CNS Drugs 2000; 13(6): 421-431 [80%]

Books

REF 40.Castle D, Hood S, Kyrios M. (eds) Anxiety Disorder: Current Controversies, Future Directions. Australian Postgraduate Medicine, Melbourne. 2007. [33% as editor]
REF 41.Nutt DJ; Argyropoulos S; Hood SD. Clinician’s Manual on Anxiety Disorders and Comorbid Depression. London: Science Press; 2000 [Italian edition 2001]. [40%]

Book Chapters

REF 42.Davies, S. J., Hood, S. D., Christmas, D., Nutt D.J. Psychiatric disorders and cardiovascular disease. Anxiety, depression and hypertension. In Psychological Factors and Cardiovascular Disorders: The Role of Psychiatric Pathology and Maladaptive Personality Features (ed L. Sher), New York: Nova Science Publishers. 2008 [30%]
REF 43.Hood SD, Robinson H, Nutt DJ. In Castle D, Hood S, Kyrios M. (eds) Anxiety Disorder: Current Controversies, Future Directions. Australian Postgraduate Medicine, Melbourne. Chapter 20: New directions in biological treatments for anxiety disorders. 2007. [80%]
REF 44.Hood SD, Robinson H, Nutt DJ. In Castle D, Hood S, Kyrios M. (eds) Anxiety Disorder: Current Controversies, Future Directions. Australian Postgraduate Medicine, Melbourne. Chapter 17: Pharmacological treatments for anxiety disorders: How do they work? 2007. [80%]
REF 45.Hood SD, Nutt DJ. In Crozier WR, Alden LE, editors. The essential handbook of social anxiety disorder for clinicians. Chichester: John Wiley & Sons, Ltd; Chapter 13: Psychopharmocological Treatments: An overview. 2005 [85%]
REF 46.Bell C, Hood SD. In Joyce P, Mitchell P, editors. Mood Disorders. Chapter 25: Mood Disorders and Anxiety Disorders. Sydney: UNSW Press; 312-324. 2005. [50%]
REF 47.Hood SD, Nutt DJ. In Crozier WR, Alden LE, editors. International Handbook of Social Anxiety: Research and Interventions relating to the Self and Shyness. Chichester: John Wiley & Sons, Ltd.; Chapter 21. Psychopharmacological Treatments – An Overview. September 2001 [85%].

Book Reviews

REF 48.Essential Psychopharmacology: The Prescriber’s Guide. Journal of Psychopharmacology 2005 19: 681-682 [100%]
REF 49.Anxiety Disorders: Pathophysiology and Pharmacological Treatment (Emilien, Durlach, Lepola, Dinan). International Journal of Psychiatry in Clinical Practice. 2003;7:72-3. [100%]
Other Publications
REF 50.Hood, SD, Orr K, Nutt DJ. Antipsychotics. Psychiatry 2007; 6(7): 295-300. [80%]
REF 51.Hood, SD. Nutt DJ. Psychopharmacology: Antipsychotics. Psychiatry 2004; 3(7): 27-30. [85%]
REF 52.Hood, S.D. Adult Attention Deficit Disorder Treatment. Pulse 2003;63(2):68 [90%]
REF 53.Hood, S.D. Are there effective SAD treatments? Pulse 2000;60(14):112. [90%]
REF 54.Hood, S.D. Low dose antidepressant prescription by GP’s. Pulse. 2000 60(13):120 [90%]
REF 55.Hood, S.D. Why are antiepileptics useful in depression? Pulse. 2000; 60(8). [90%]
REF 56.Hood, S.D. Which SSRI has least effect on sexual arousal? Pulse. 1999; 59(50). [90%]
REF 57.Hood, S.D. and D.J. Nutt, Dysthymia: nosology and treatment. Perspectives in Depression 1999;7(3):3-7. [90%]
REF 58.Hood, S.D. and D.J. Nutt, How I Treat – St John’s Wort. Practitioner. November 1999;243:779-786. [90%]
REF 59.Hood, S.D., Argyropoulos S, Nutt D.J. SSRI’s and Social Phobia (Social Anxiety Disorder). Practical Issues in Mood and Anxiety Disorders. 1999; 9: 1-8. [65%]
REF 60.Hood, S.D. and D.J. Nutt, Panic Disorder CNS. 2000; 2(4): 7-11. [75%]
REF 61.Hood, S.D., Argyropoulos S, Nutt D.J. The efficacy of Paxil (paroxetine) for panic disorder. Current Practice of Medicine 1999;2(8):159-62. [80%]
REF 62.Hood, S.D. and D.J. Nutt, Depression: Is improvement enough? Medical Dialogue, 1999 No. 508. [75%]

Consumer Publications

REF 63.Hood, S.D., A Living Hell: Psychological Treatments for Depression, 1999, BBC Education. [100%]

Reports & Guidelines

REF 64.Academic Perceptions of Teaching Environment (APOTE) survey. May 2011. The University of Western Australia. (steering committee).
REF 65.Anxiety Guidelines. Western Australian Psychotropic Drugs Committee (WAPDC). August 2008, http://www.watag.org.au/wapdc/guidelines.cfm .
REF 66.Antipsychotic Drug Guidelines. Western Australian Psychotropic Drugs Committee (WAPDC). version 3, August 2006, http://www.watag.org.au/wapdc/guidelines.cfm .
REF 67.Sedation of Acutely Agitated Adult Patients Prior to Transportation. Western Australian Psychotropic Drugs Committee (WAPDC). January 2006, http://www.watag.org.au/wapdc/guidelines.cfm .
REF 68.Antidepressants. Western Australian Psychotropic Drugs Committee (WAPDC). January 2005, http://www.watag.org.au/wapdc/guidelines.cfm .
REF 69.Hood, S. D, McDonough, S, and Finn, M. Emergency Department Mental Health Triage And Consultancy Service "EMTACS". Pilot Phase: June – August 2001. Directorate of Mental Health, Fremantle Hospital and Health Service. September 2001.
REF 70.Hood, S. D and Finn, M. Implementing The WA Strategic Quality Plan 1998 - 2003: Expression of Interest. Implementing Quality Initiatives in the State's Public Hospitals and Health Services. A submission by the Mental Health Directorate, Fremantle Hospital and Health Services. 2001.

Roles, responsibilities and expertise

University of Western Australia
2009-Academic Perceptions of Teaching Environment Committee (APOTE)
2009-10 Member, Academic Board
2008Executive Committee, Clinical Academics Staff Association (CASA)
(President, 2011+)
Faculty of Medicine, Dentistry & Health Sciences
2009-Personal and Professional Development (PPD) Working Group
2009-10 UWA / UNDA Interim Clinical Places Committee
2010-Medical Curriculum Committee (MCC)
2011- MD Curriculum Contents Committee (MDCCC)
2011-Chair, Systems Subcommittee of MDCCC

School of Psychiatry & Clinical Neurosciences
2011Acting Head of School (August)
2011Co-ordinator 6th Year MBBS Psychiatry
2004-Undergraduate Teaching Committee
2004-8Research & Publications Committee
2004-8Postgraduate Committee
2009 Research, Publications & Postgraduate Studies Committee
2009-Personal and Professional Development Advisor for School
2009-Finance Officer
2009-Chair, Research InnOvation Scholarship Education Teaching Training & CollAboration (ROSETTA) Unit (& Founding Member)

Future research

DBS in Major Depression
DBS in OCD

Funding received

•Hood SD, Lind CRP. 2011: Sir Charles Gairdner Hospital Research Advisory Committee Project Grant. Dual target deep brain stimulation trial for obsessive compulsive disorder – a feasibility study. $AU 29,956

•Thompson PL, Hood SD, Davidson P, Crittenden J. 2010: Sir Charles Gairdner Hospital Research Advisory Committee Project Grant. Identifying those at risk of developing depression following acute coronary syndrome: A novel screening strategy. $AU 19,994.88

•Hood SD. University of Western Australia, UWA Research Grants Scheme 2007: The role of serotonin in experimental anxiety in healthy volunteers following chronic administration of the selective serotonin reuptake inhibitor escitalopram. $AU 29970.83

•Hulse G, Hood SD. Assessment of the impact of the smoking cessation policy on the wellbeing of mental health in-patients and the implications for hospital staff. 2007 Mental Health Strategy Funding Special Project Submission. January 2007 $70,951

•Nutt DJ. Raine Medical Research Foundation, 2006 Raine Visiting Professorship $10,000 (Dr Hood successfully applied for this funding).

•Hood SD. Raine Medical Research Foundation, 2005 Raine Priming Grant Awards, 2005-6: Tryptophan depletion in patients with SSRI-remitted anxiety disorders. $AU 118,631.

•Hood SD, Kaye J. University of Western Australia, UWA Research Grants Scheme 2005: Serotonin regulation of the human stress response. (RA/1/485). $AU 18,036.53.

•Avon and Wiltshire Mental Health Partnership NHS Trust, Small Project Grants, June 2003: Tryptophan depletion in patients with panic disorder who have responded to cognitive behavioural therapy. £UK 4,811.

Memberships

Membership of Learned Organisations

Full Registration with Medical Board of WA (#10138)
Full Registration with General Medical Council UK as a Medical Practitioner with Specialist Registration in General Psychiatry (#4163734)
Fellow of the Royal Australian and New Zealand College of Psychiatrists (Feb. 2004)
Clinical Research Fellow, Psychopharmacology Unit, University of Bristol (since 1999)
Member of the Australian Society for Psychiatric Research (since 2004)
Member of British Association for Psychopharmacology (since 1999)
Member of World Federation of Societies of Biological Psychiatry (since 2000)
Member of the International College of Affective Neuroscience (ICANS) (since 2009)
Member of Doctors-in-Training Committee, Australian Medical Association, WA Branch (2001)
AMA Representative, Association of Psychiatrists in Training Western Australian Branch (2001)
Member of the Aropax Advisory Board (Australia) 2002.
Member of the Duloxetine Advisory Board (Australia) 2007-
Member of the Pristiq Advisory Board (Australia) 2010- (Chair, 2011)
Member, RANZCP (WA) Scholarships Committee (2004-5).
Foundation Member, Bristol Anxiety Research Group (BARG). (Since 2002).
Chair, Bentley Research Interest Group (BRIG). (2004-6)
Foundation Member, UWA Private Clinics Australia Research Executive (UP-CARE) (since 2005).
Member, North Metropolitan Area Mental Health Services Human Research Ethics Committee 2005-6.
Membership of RANZCP Committees
Member, Specialist IMG Dual Pathway Assessment Panel (W. Aust) 2009-2010
Member, RANZCP Board of Research (Australasia) 2005-2009
Member, RANZCP Committee for Research (Australasia) 2009-
RANZCP Research & Education Foundation (Australasia) 2007-
Organising Committee, 41st Congress RANZCP, Perth, Australia, 28 May – 1 Jun 2006.
Programming Subcommittee, 41st Congress RANZCP, Perth, Australia, 28 May – 1 Jun 2006.

Membership of Organisations with Consumer / Carer Involvement

Member, North Metropolitan Human Research Ethics Committee 2006
Executive Member, Anxiety Disorders Foundation (ADF) of Western Australia 2001-4
Vice President 2005-7.
Chair, General Practice Reference Group. Bentley Health Service & Canning Division of General Practice. 2004-9
Member, Fremantle Hospital and Health Services General Practitioners Advisory Group 2001

Membership of Health Department of WA Committees

2005:Hospital Discharge Summaries Forum
2005:Western Australian Medication Safety Group (Occasional Proxy for Chief Psychiatrist)
2004 -:Western Australian Psychotropic Drug Committee (WAPDC) (Chair 2006-)
2005:Pharmacy Reform Project Control Group
2006-7:Mental Health Network Coordinating Group of WA – Tertiary Education Representative
2007-:Western Australian Therapeutics Advisory Group (WATAG)
2007:Mental Health Network Smokefree Coordination Group
2008-:Member, Medical Board of WA (for Western Australia Police & Department of Corrective Services).
2010:(April – May): Acting Clinical Director, Department of Psychiatry, SCGH.

Membership of Editorial Boards

2005-:Recent Patents on CNS Drug Discovery
2010-:Current Psychiatry Reviews

Honours and awards

2011 OctWestern Australian Medical Students’ Society: 2011 Clinical Tutor of the Year.

2008 JulBritish Association for Psychopharmacology Clinical Poster Prize: Hince DA, Hood SD, Robinson H, Rich A, Potokar J, Davies SJC, Argyropoulos SV, Nash J, Morris K, Potter J, Forward S, Morris L, Nutt DJ. Selective serotonin reuptake inhibitor-remitted patients with Generalised Anxiety Disorder do not show an increase in symptoms following acute tryptophan depletion. 2008 Summer Conference of the British Association for Psychopharmacology. Harrogate, UK.

2008 AprWinner, 2007 Excellence in Teaching Awards: Small Group Teaching in a Clinical and/or Practicum setting. Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia

2006 JunLetter of thanks from Richard H Baker, Member of Congress of the United States, to Prime Minister John Howard re Lousiana Hurricane Choir Project. 16 Jun 2006.

2005 OctECNP - ACNP Exchange Award. Davies SJC, Hood SD, Argyropoulos SV, Bell CJ, Jackson P, Nutt DJ, Potokar J. Hypertension And Anxiety – Serotonin Depletion Associated With Consistent Excess Pressor Response To Stress Challenge In Patients With Treated Anxiety Disorders. 18th ECNP Congress. Amsterdam, The Netherlands, 22-26 Oct 2005.

2005 OctECNP Poster Award. Davies SJC, Hood SD, Argyropoulos SV, Bell CJ, Jackson P, Nutt DJ, Potokar J. Hypertension And Anxiety – Serotonin Depletion Associated With Consistent Excess Pressor Response To Stress Challenge In Patients With Treated Anxiety Disorders. 18th ECNP Congress. Amsterdam, The Netherlands, 22-26 Oct 2005.

2004 Oct.ECNP Travel Award: J.R. Nash, P.A. Sargent, E.A. Rabiner, S.D. Hood, S.V. Argyropoulos, P.M. Grasby, D.J. Nutt. Altered 5HT1A binding in panic disorder demonstrated by positron emission tomography. 17th ECNP Congress. Stockholm Sweden, 9-13 Oct 2004.

2003 Nov.Best Poster: Biannual Meeting of the South West Division of the Royal College of Psychiatrists, UK.

2003 Jul.British Association for Psychopharmacology Organon Journal Prize: Bell C, Forshall S, Adrover M, Nash J, Hood SD, Argyropoulos S, Rich A, Nutt, DJ. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. Journal of Psychopharmacology 2002; 16 (1): 5-14

2001 Australian and New Zealand Mental Health Service Silver Achievement Award, “Specialist Service or Part of a Larger Service” Category: Carr P, Castle DJ, Hood SD, Theobold J, and Twomey N. The Mental Health Services Conference Inc. of Australia and New Zealand: 2001 Achievement Awards Competition. Category 5. Fremantle Hospital GP Liaison Service. 2001

Previous positions

Consultant Psychiatrist
Swan Valley Centre
Eveline Road
Middle Swan
Perth, Australia

Clinical Research Fellow
Psychopharmacology Unit
University of Bristol
Dorothy Hodgkin Building
Whitson Street
Bristol, UK
BS1 3NY

Teaching

1.Examiner
•MB Final Clinical Examination in Psychiatry, Bristol, UK
oJune 1999
oJanuary, March, May 2003
•MB Final Written Examination in Psychiatry, Bristol, UK: June 2003
•MBBS 4th Year Clinical Examinations, Perth, Australia: August 2004-
•MBBS Final Clinical Examinations, Perth, Australia: November 2004-


2.Academic Supervision
•PhD Supervisor, University of WA 2006-
o“Philosophical Theories Of Scientific Change - The Case Of Carnap, The Post-Positivists, and the Development of Psychopharmacology” (Hoskens)
•BMed Sci student, University of WA, 2006.
o“Tryptophan depletion in patients with SSRI-remitted anxiety disorders” (Robinson)
oGrade: Honors, First Class
•4th Year MBBS Science Research & Discovery Supervisor
oSerotonin regulation of the human stress response.
(Cirillo & Robinson)
o“Tryptophan depletion in patients with SSRI-remitted generalised anxiety disorder”
(Forward, Potter & Morris).
o“Tryptophan depletion in patients with SSRI-remitted obsessive compulsive disorder”
(Patton, Rowell & Milne).
•MSc students, University of Bristol 1999.
oMasters Dissertation: Core physical symptoms in social anxiety disorder.
oLiterature Review: Dysthymia.
•BSc student, University of Bristol, 2003.
oDissertation:A post-hoc analysis of Tryptophan Depletion studies in Panic Disorder
3.University Teaching
•Site Co-ordinator Bentley Campus (4th Year MBBS) Psychiatry. 2005-. University of Western Australia, Perth.
•Senior Lecturer (locum), Notre Dame University, Fremantle, Australia 2005-7
•Member, Communications & Clinical Practice Committee (CCP), Notre Dame 2005-6
•Completed Foundations of University Teaching & Learning Course, Semester 2, 2004. University of Western Australia, Perth. (http://www.csd.osds.uwa.edu.au/about/workshop.asp?workshop_id=3)
•Tutor, 2nd Year MBBS students, Semester 2 2004. University of Western Australia, Perth.
•Member, Faculty of Medicine & Dentistry Year 3 and 4 Committee 2004. University of Western Australia, Perth.
•Member, Board of Examiners, 2nd & 3rd Yr MBBS. December 2004. University of Western Australia, Perth.
•MRC Psychiatry Part II Course Lectures, Bristol UK
o30 May 2003: Anxiety Disorders

4.Postgraduate Psychiatric Training
•RANZCP Approved Supervisor (Community Adult Psychiatry) 2004+
•Supervised two RANZCP trainee registrars 2004+

Current external positions

Consultant Psychiatrist
Sir Charles Gairdner Hospital
Verdun Street
Nedlands 6009
Perth, Australia

Honorary Clinical Research Fellow
Psychopharmacology Unit
University of Bristol
Dorothy Hodgkin Building
Whitson Street
Bristol, UK
BS1 3NY

Current projects

1.Tryptophan Depletion in SSRI- Remitted Generalised Anxiety Disorder Patients (RA/4/1/1193)
2.Tryptophan Depletion in SSRI- Remitted Obsessive Compulsive Disorder Patients (RA/4/1/1193
3.The Hurricane Choir Project: A Community Initiative Promoting Better Health Outcomes in the Aftermath of a Disaster (RA/4/1/1444)
4.An Eight-Week, Multicentre, Randomised, Double-Blind, Placebo- Controlled Study, Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Doses (100 mg and 30 mg Once Daily) of Saredutant in Patients with Generalized Anxiety Disorder (EFC5582)

Research profile

Research profile and publications